Detalles de la búsqueda
1.
Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis.
Ann Rheum Dis
; 81(8): 1096-1105, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459695
2.
Response to: Correspondence on "HLA-DR 'naturally' presented peptides: you will find what you have pulsed with" by Roudier.
Ann Rheum Dis
; 82(9): e204, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595389
3.
Blocking of p38 and transforming growth factor ß receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis.
Arthritis Rheum
; 65(1): 120-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22972370
4.
Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharide-stimulated collagen-loaded dendritic cells.
Clin Dev Immunol
; 2013: 296031, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23818913
5.
Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis.
Eur Cytokine Netw
; 18(3): 127-35, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17823080
6.
Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype.
Eur Cytokine Netw
; 18(2): 78-85, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17594940
7.
Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response.
Front Immunol
; 8: 1350, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29109727
8.
Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?
Immunobiology
; 211(1-2): 75-84, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16446172
9.
NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Eur Cytokine Netw
; 17(2): 125-30, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16840031
10.
Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T Cells.
Front Immunol
; 7: 359, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698654
11.
Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.
Front Immunol
; 7: 458, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27826300
12.
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.
PeerJ
; 4: e2300, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27635311
13.
Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity.
Front Immunol
; 6: 488, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26441992
14.
Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
Autoimmun Rev
; 14(6): 517-27, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25633325
15.
Retinaldehyde dehydrogenase activity is triggered during allograft rejection and it drives Th1/Th17 cytokine production.
Immunobiology
; 220(6): 769-74, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592248
16.
Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo.
Immunotherapy
; 7(2): 101-10, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25713986
17.
Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis.
Eur Cytokine Netw
; 14(3): 128-33, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14656685
18.
The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.
Eur Cytokine Netw
; 15(4): 364-70, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15627647
19.
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.
Arthritis Res Ther
; 12(2): R68, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20398308
20.
[The influence of -238 and -308 TNF alpha polymorphisms on the pathogenesis and response to treatment in rheumatoid arthritis]. / Papel de los polimorfismos -238 y -308 del promotor del factor de necrosis tumoral alfa en la patogenia y respuesta al tratamiento anti-factor de necrosis tumoral alfa en artritis reumatoide.
Rev Med Chil
; 133(9): 1089-95, 2005 Sep.
Artículo
en Español
| MEDLINE | ID: mdl-16311703